Logo image of ALBO

ALBIREO PHARMA INC (ALBO) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:ALBO - US01345P1066 - Common Stock

44.15 USD
-0.1 (-0.23%)
Last: 3/2/2023, 8:00:01 PM
44.33 USD
+0.18 (+0.41%)
After Hours: 3/2/2023, 8:00:01 PM
Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to ALBO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 42.84. This target is -2.97% below the current price.
ALBO was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about ALBO.
In the previous month the buy percentage consensus was at a similar level.
ALBO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
ALBO Historical Analyst RatingsALBO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -73 -66 -59 -52 -45 -38 -31 -24 -17 -10 -3 5 10

Price Target & Forecast

Price Low Median Mean High 44.1542.4242.8442.8444.10 - -3.92% -2.97% -2.97% -0.11%
ALBO Current Analyst RatingALBO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2023-02-15 HC Wainwright & Co. Reiterate Neutral
2023-01-11 Guggenheim Downgrade Buy -> Neutral
2023-01-11 Cowen & Co. Downgrade Outperform -> Market Perform
2023-01-11 Jefferies Downgrade Buy -> Hold
2023-01-10 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-01-09 Wedbush Downgrade Outperform -> Neutral
2022-10-13 HC Wainwright & Co. Maintains Buy
2022-10-12 Baird Maintains Outperform
2022-09-08 Guggenheim Initiate Buy
2022-08-16 Wedbush Maintains Outperform
2022-08-16 Baird Maintains Outperform
2022-08-16 HC Wainwright & Co. Maintains Buy
2022-05-17 Baird Maintains Outperform
2021-11-05 HC Wainwright & Co. Maintains Buy
2021-09-16 Wedbush Maintains Outperform
2021-07-21 Wedbush Maintains Outperform
2021-07-21 HC Wainwright & Co. Maintains Buy
2021-03-01 Piper Sandler Maintains Overweight

ALBIREO PHARMA INC / ALBO FAQ

What is the average price target for ALBIREO PHARMA INC (ALBO) stock?

13 analysts have analysed ALBO and the average price target is 42.84 USD. This implies a price decrease of -2.97% is expected in the next year compared to the current price of 44.15.


Can you provide the consensus rating for ALBIREO PHARMA INC stock?

The consensus rating for ALBIREO PHARMA INC (ALBO) is 76.9231 / 100 . This indicates that analysts generally have a positive outlook on the stock.